How do COVID-19 outcomes vary by race and gender? PermanenteDocs COVID19 SARSCoV2 Pandemic COVIDOutcomes
By Bhavana KunkalikarNov 29 2022Reviewed by Aimee Molineux In a recent study published in PLoS ONE, researchers investigated the variations in coronavirus disease 2019 testing and severe outcomes according to race, ethnicity, and gender.
The Corona-Infectious-Virus Epidemiology Team involves three integrated health systems, two academic health clinics, and one interval group.
Results The study population comprised 5,958,908 patients, including 5,955,269 from clinical cohorts and 3,639 from the interval cohort. Among these, 5,724 were hospitalized due to COVID-19 clinical syndrome diagnoses, and 1,399 died following a positive SARS-CoV-2 PCR test result.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Alterations of the fecal microbiota in relation to acute COVID-19 infection and recovery - Molecular BiomedicinePeople with acute COVID-19 due to SARS-CoV-2 infection experience a range of symptoms, but major factors contributing to severe clinical outcomes remain to be understood. Emerging evidence suggests associations between the gut microbiome and the severity and progression of COVID-19. To better understand the host-microbiota interactions in acute COVID-19, we characterized the intestinal microbiome of patients with active SARS-CoV-2 infection in comparison to recovered patients and uninfected healthy controls. We performed 16S rRNA sequencing of stool samples collected between May 2020 and January 2021 from 20 COVID-19-positive patients, 20 COVID-19-recovered subjects and 20 healthy controls. COVID-19-positive patients had altered microbiome community characteristics compared to the recovered and control subjects, as assessed by both α- and β-diversity differences. In COVID-19-positive patients, we observed depletion of Bacteroidaceae, Ruminococcaceae, and Lachnospiraceae, as well as decreased relative abundances of the genera Faecalibacterium, Adlercreutzia, and the Eubacterium brachy group. The enrichment of Prevotellaceae with COVID-19 infection continued after viral clearance; antibiotic use induced further gut microbiota perturbations in COVID-19-positive patients. In conclusion, we present evidence that acute COVID-19 induces gut microbiota dysbiosis with depletion of particular populations of commensal bacteria, a phenomenon heightened by antibiotic exposure, but the general effects do not persist post-recovery.
Read more »
Researchers propose the tools and frameworks of EBM+ to help overcome the COVID-19 pandemicResearchers propose the tools and frameworks of EBM+ to help overcome the COVID-19 pandemic bmj_company UniofOxford UofT UNSW COVID19 coronavirus covid pandemic medicine evidencebasedmedicine
Read more »
Establishment of quantitative scale for long COVID stigma estimation among UK residentsResearchers developed and validated the long coronavirus disease (COVID) stigma scale (LCSS) to quantify the burden of long COVID stigma in the United Kingdom (UK).
Read more »
Big UK trial to find best drugs to fight fluCovid scientists will be testing different medications to see what works against winter flu.
Read more »
Large COVID vaccination study found that thrombosis and thrombocytopenia are very rare complicationsLarge COVID vaccination study found that thrombosis and thrombocytopenia are very rare complications Coronavirus Disease COVID Cardiology Thrombosis Thrombocytopenia NatureComms UniofOxford UV_EG UniBarcelona
Read more »